相关实验视频
Updated: Jan 9, 2026

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
7.0K
新型2-pyrazoline-1-carboxamides作为抗阿尔茨海默症药物的合成,生物评估和分子对接
Fatih Tok1, Funda Aleyna Özer2, Zeynep Sude Kuzu2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, İstanbul, Türkiye.
Future medicinal chemistry
|December 2, 2025
概括
新的酸衍生物显示出作为阿尔茨海默病治疗的前景. 这些化合物表现出强烈的抗氧化和胆酶抑制作用,其中一种化合物显示出穿越血脑屏障的潜力.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 计算化学计算化学
背景情况:
- 阿尔茨海默病 (AD) 管理依赖胆酶抑制剂来缓解症状和减缓进展.
- 需要新的治疗药物来有效地对抗AD.
研究的目的:
- 合成和评估新型的2-pyrazoline-1-carboxamide衍生物作为潜在的阿尔茨海默病治疗药物.
- 研究这些化合物的抗氧化和胆化酶抑制活性.
主要方法:
- 合成2-pyrazoline-1-carboxamide衍生物的合成方法.
- 使用IR,1H-NMR,13C-NMR和元素分析进行结构阐明.
- 在体外评估抗氧化剂和胆酶 (AChE,BChE) 活动.
- 包括分子对接,分子动力学,MEP和FMO计算在内的in silico研究使用DFT.
主要成果:
- 化合物7和8显示出显著的抗氧化活性.
- 化合物7和8是AChE和BChE的强有力的抑制剂,其IC50值与兰胺相似或优于兰胺.
- 在基分析表明,化合物7对AChE和BChE具有良好的结合亲和力.
- 根据ADME的预测,化合物7具有血脑屏障的透性.
结论:
- 合成的2-pyrazoline-1-carboxamide衍生物,特别是化合物7和8,显示出作为阿尔茨海默病治疗剂的显著潜力.
- 化合物7的有利的形状和血脑屏障透值得进一步研究AD治疗.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K

